Abiopharma

🔍 Kropotova Alexandra (Executive)

Company: SAB Biotherapeutics, Inc. (SABS)

Report Date: 2025-12-11

Detailed Transactions and Holdings:

• Sold 988 shares of Common Stock (Direct)
  Date: 2025-12-11 | Code: F | equity_swap_involved: false | shares_owned_after: 44,284.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2

Footnotes:

• F1: Represents shares of the Issuer's common stock ("Common Stock") withheld to statisfy tax withholding requirements on the vesting of the Issuer's restricked stock units ("RSUs").
• F2: Includes 31,946 shares of Common Stock and 12,338 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended.
• F3: Each RSU represents a contingent right to receive one share of Common Stock.